Zevra Therapeutics Inc. (ZVRA) stock news · rev $106.5M
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
This ZVRA news page leads with what Zevra Therapeutics Inc. filed — not a scraped headline mill.
No cached 8-K sentence for ZVRA yet. We will not pad this page with generic market recap.
Latest reported ZVRA revenue for 2025-12-31 was $106.5M. Net income was $83.2M. Revenue was up 350.9% from 2024-12-31 to 2025-12-31. ZVRA currently screens at market cap $745.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ZVRA stock page; for the tape open the quote page.
ZVRA stock news FAQ
What are ZVRA's latest revenue and net income?
Latest cached Zevra Therapeutics Inc. (ZVRA) revenue for Dec 31, 2025 was $106.5M. Net income was $83.2M. Statements: https://lician.com/financials/zvra
How did ZVRA revenue change from the prior cached period?
Cached Zevra Therapeutics Inc. (ZVRA) revenue was up 350.9% from $23.6M (Dec 31, 2024) to $106.5M (Dec 31, 2025). Statements: https://lician.com/financials/zvra
What is ZVRA's market cap?
Zevra Therapeutics Inc. (ZVRA) market cap is $745.4M on the latest cached fundamentals snapshot.
What kind of company is ZVRA?
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Where is ZVRA stock news listed?
Cached stock news for Zevra Therapeutics Inc. (ZVRA) is listed at https://lician.com/news/zvra. Filings: https://lician.com/sec/zvra
Not investment advice.